annual shareholders equity:
$255.30M-$20.12M(-7.30%)Summary
- As of today (July 7, 2025), RARE annual stockholders equity is $255.30 million, with the most recent change of -$20.12 million (-7.30%) on December 31, 2024.
- During the last 3 years, RARE annual shareholders equity has fallen by -$667.26 million (-72.33%).
- RARE annual shareholders equity is now -77.88% below its all-time high of $1.15 billion, reached on December 31, 2020.
Performance
RARE Shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly shareholders equity:
$144.25M-$111.05M(-43.50%)Summary
- As of today (July 7, 2025), RARE quarterly stockholders equity is $144.25 million, with the most recent change of -$111.05 million (-43.50%) on March 31, 2025.
- Over the past year, RARE quarterly shareholders equity has increased by +$3.98 million (+2.84%).
- RARE quarterly shareholders equity is now -87.50% below its all-time high of $1.15 billion, reached on December 31, 2020.
Performance
RARE quarterly shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders equity Formula
Shareholders Equity = Total Assets − Total Liabilities
RARE Shareholders equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.3% | +2.8% |
| 3 y3 years | -72.3% | -81.9% |
| 5 y5 years | -61.0% | -76.3% |
RARE Shareholders equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -72.3% | at low | -78.7% | +354.8% |
| 5 y | 5-year | -77.9% | at low | -87.5% | +354.8% |
| alltime | all time | -77.9% | +2298.7% | -87.5% | +354.8% |
RARE Shareholders equity History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $144.25M(-43.5%) |
| Dec 2024 | $255.30M(-7.3%) | $255.30M(-26.4%) |
| Sep 2024 | - | $346.83M(-19.8%) |
| Jun 2024 | - | $432.42M(+208.3%) |
| Mar 2024 | - | $140.26M(-49.1%) |
| Dec 2023 | $275.41M(-21.9%) | $275.41M(+768.4%) |
| Sep 2023 | - | $31.71M(-75.4%) |
| Jun 2023 | - | $129.03M(-41.5%) |
| Mar 2023 | - | $220.48M(-37.5%) |
| Dec 2022 | $352.49M(-61.8%) | $352.49M(-24.8%) |
| Sep 2022 | - | $468.83M(-30.9%) |
| Jun 2022 | - | $678.07M(-14.9%) |
| Mar 2022 | - | $796.42M(-13.7%) |
| Dec 2021 | $922.56M(-20.1%) | $922.56M(-1.2%) |
| Sep 2021 | - | $933.67M(-4.0%) |
| Jun 2021 | - | $972.17M(-7.8%) |
| Mar 2021 | - | $1.05B(-8.6%) |
| Dec 2020 | $1.15B(+76.6%) | $1.15B(+73.3%) |
| Sep 2020 | - | $666.19M(-4.2%) |
| Jun 2020 | - | $695.59M(+14.2%) |
| Mar 2020 | - | $609.15M(-6.8%) |
| Dec 2019 | $653.76M | $653.76M(-10.1%) |
| Sep 2019 | - | $727.26M(-11.3%) |
| Jun 2019 | - | $819.79M(-7.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $886.73M(+45.6%) |
| Dec 2018 | $608.91M(+58.8%) | $608.91M(-8.1%) |
| Sep 2018 | - | $662.60M(-5.9%) |
| Jun 2018 | - | $703.97M(-2.7%) |
| Mar 2018 | - | $723.66M(+88.7%) |
| Dec 2017 | $383.45M(-19.1%) | $383.45M(+4.9%) |
| Sep 2017 | - | $365.56M(-14.9%) |
| Jun 2017 | - | $429.45M(-12.1%) |
| Mar 2017 | - | $488.48M(+3.1%) |
| Dec 2016 | $473.97M(-10.8%) | $473.97M(+4.0%) |
| Sep 2016 | - | $455.89M(+2.7%) |
| Jun 2016 | - | $443.89M(-9.4%) |
| Mar 2016 | - | $489.82M(-7.8%) |
| Dec 2015 | $531.09M(+187.2%) | $531.09M(-7.9%) |
| Sep 2015 | - | $576.76M(+80.6%) |
| Jun 2015 | - | $319.28M(-6.4%) |
| Mar 2015 | - | $341.12M(+84.4%) |
| Dec 2014 | $184.94M(+269.1%) | $184.94M(-7.2%) |
| Sep 2014 | - | $199.33M(+30.2%) |
| Jun 2014 | - | $153.08M(-7.6%) |
| Mar 2014 | - | $165.71M(+230.7%) |
| Dec 2013 | $50.11M(-40.6%) | $50.11M(-18.1%) |
| Sep 2013 | - | $61.15M(-27.5%) |
| Dec 2012 | $84.34M(+692.4%) | $84.34M |
| Dec 2011 | $10.64M | - |
FAQ
- What is Ultragenyx Pharmaceutical Inc. annual stockholders equity?
- What is the all time high annual shareholders equity for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. annual shareholders equity year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. quarterly shareholders equity year-on-year change?
What is Ultragenyx Pharmaceutical Inc. annual stockholders equity?
The current annual shareholders equity of RARE is $255.30M
What is the all time high annual shareholders equity for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high annual stockholders equity is $1.15B
What is Ultragenyx Pharmaceutical Inc. annual shareholders equity year-on-year change?
Over the past year, RARE annual stockholders equity has changed by -$20.12M (-7.30%)
What is Ultragenyx Pharmaceutical Inc. quarterly stockholders equity?
The current quarterly shareholders equity of RARE is $144.25M
What is the all time high quarterly shareholders equity for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high quarterly stockholders equity is $1.15B
What is Ultragenyx Pharmaceutical Inc. quarterly shareholders equity year-on-year change?
Over the past year, RARE quarterly stockholders equity has changed by +$3.98M (+2.84%)